Jul
21
Birmingham, West Midlands — (TechSonian) — 21st July 2014 — Himax Technologies, (NASDAQ:HIMX) revealed that financial outcome for the first quarter finished March 31, 2014. They are pleased to report another quarter of year over year growth and meeting our guidance for revenues, gross margin and EPS, quoted Mr. Jordan Wu, President and Chief Executive Officer of Himax.
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) opened its shares at the price of $5.75 for the day. Its closing price was $5.96 after gaining +3.11% for the day. The company traded with the total volume of 3.16 million shares, while its average trading volume remained 4.01 million shares. The beta of HIMX stands at 1.74.
For How Long HIMX will Fight for Profitability? Read This Trend Analysis report
Grupo Financiero Galicia, (NASDAQ:GGAL) operates as a financial services holding company in Argentina. The company operates through Banking, Regional Credit Cards, CFA Personal Loans, and Insurance segments.
Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) percentage change surged +3.11% to close at $16.92 with the total traded volume of 850,217.00 shares, and average volume of 880,070.00. The 52 week range of the stock remained $5.30 – $17.35, while its day lowest price was $16.41 and it hit its day highest price at $17.35.
For How Long GGAL’s Gloss will Attract Investors ? Find out via this report
Nordic American Tanker Ltd (NYSE:NAT) 1st quarter 2014 announced its dividends. Cash dividend of $0.23 declared earlier. Strongly improved operating cashflow. Net income positive for the first time in four years.
Nordic American Tanker Ltd (NYSE:NAT) started its trading session with the price of $9.01 and closed at $9.30 by scoring +3.10%. NAT’s stocks traded with total volume of 1.24 million shares, while the average trading volume remained 1.37 million shares. The beta of NAT stands at 1.13. Day range of the stock was $9.01 -$9.35.
Will NAT Continue To Move Higher? Find Out Here
Qiagen NV (NASDAQ:QGEN) declared the launch of 14 new GeneReadTM DNAseq V2 gene panels targeting an extensive range of cancer-related genes or gene regions. Gene panels are an integral part of many next-generation sequencing (NGS) workflows. They are used to enrich genes of interest in a sample prior to sequencing runs and as such can be seen as the core assay in the workflow. QIAGEN’s new GeneRead panels are customizable to include other genes or gene regions of clinical or biological interest and are compatible with any NGS sequencer. They are part of QIAGEN’s industry-leading sample-to-library workflows, which are helping to drive the growing use of NGS in clinical applications.
Qiagen NV (NASDAQ:QGEN) ended its day with the gain of +3.07% and closed at the price of $25.18 after opening at $24.80. Stock traded during its last trading session with the total volume of 1.35 million shares, as compared to its average volume of 843,262.00 shares.
Why Should Investors Buy QGEN After The Recent Gain? Just Go Here and Find Out
Open all references in tabs: [1 – 5]
Comments
Leave a Reply
You must be logged in to post a comment.